Collegium Pharmaceutical (COLL) Forms DEF 14A Filing on April 10
Published on 4/10/2026
AI Summary
Summarized by AI from the source belowCollegium Pharmaceutical (COLL) has filed a DEF 14A with the SEC dated April 10. This filing includes essential information regarding upcoming shareholder meetings and proposals for the company's governance. It is a standard procedure in ensuring compliance with regulatory requirements. Market participants will review this filing to assess any potential impacts on shareholder relations or corporate strategy.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
